Skip to content
★ Sign in to follow
SA

SpectraCure AB (publ) Stock: price and insider trades · Sweden

ISIN SE0009357114SE·

No insider purchase over the last 90 days. The latest, by Johannes Swartling, was filed 05 Nov 2018.

SpectraCure AB (publ): what insiders have been doing

Insider filings for SpectraCure AB (publ) are scarce in the Finansinspektionen feed, the latest one published on 14 November 2019. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€4,754
1 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 14 November 2019
Declarations6 total
  • ●
    Styrelseledamot/suppleantExecutives
    5M SEK8FI-SE
    826,691 shares@ SEK 6.5013.3% of flowAktieISIN SE0011762350FI:csv-d5f50fe168cd2d1868b5
  • ●
    StyrelseordförandeExecutives
    35M SEK0FI-SE
    5,373,491 shares@ SEK 6.5086.7% of flowTeckningsrättISIN SE0011762350FI:csv-e46a2f57db745aa66051
  • ●
    CTOExecutives
    49,497 SEK0FI-SE
    9,428 shares@ SEK 5.250.0% of flowBTU (betald tecknad unit)ISIN SE0011762376FI:csv-938da54fa491b0a82636
  • ▲
    CTOExecutives
    49,497 SEK0FI-SE
    9,428 shares@ SEK 5.250.0% of flowBTU (betald tecknad unit)ISIN SE0011762376FI:csv-85ba591bff6fd7dcd23c
    Canonical exit: 28 Jan 2019 (T+90)
  • ●
    CTOExecutives
    100M SEK19FI-SE
    10,000 shares@ SEK 10,000.0099.9% of flowFI:csv-62fbcfbda0b607f19afa
  • ●
    Related company / holdingExecutives
    100,000 SEK30FI-SE
    125,000 shares@ SEK 0.80100.0% of flowISIN SE0009357114FI:csv-b595dcef266969a11c23

6 of 6 declarations

About SpectraCure AB (publ)

SpectraCure AB (publ) is a publicly traded company on the XSTO market, focused on developing innovative cancer treatments. It specializes in the use of photodynamic therapy to enhance patient outcomes.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations